Vimarsana
Biggest News Aggregation in the World

Tim Whitten News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim Whitten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Whitten Today - Breaking & Trending Today

Andrey's Picks: New Jazz from Lakecia Benjamin, Jim Self, The Necks - Vimarsana News

Andrey's Picks: New Jazz from Lakecia Benjamin, Jim Self, The Necks

Over the past decade-plus, alto saxophonist Lakecia Benjamin, 40, has been one of the key figures reinvigorating jazz from the inside. Born and raised in New York and educated at LaGuardia High School of Music & Art and Performing Arts (the famed Fame school) and the New School, Benjamin has worked with artists as diverse as David Murray and Stevie Wonder. Her last album, Pursuance, was a starry tribute to the legacy of John and Alice Coltrane.

Taiho Oncology and Astex Pharmaceuticals Present Overall Survival Data for Oral Decitabine and Cedazuridine (INQOVI®, ASTX727) in Patients With MDS and CMML Harboring TP53 Mutations at 64th ASH An... - Vimarsana News

Taiho Oncology and Astex Pharmaceuticals Present Overall Survival Data for Oral Decitabine and Cedazuridine (INQOVI®, ASTX727) in Patients With MDS and CMML Harboring TP53 Mutations at 64th ASH An...

Patients in Phase 3 ASCERTAIN study with biallelic TP53 mutations achieved median overall survival (mOS) of 13 months; mOS in the overall study po...

Taiho Oncology, Inc.: FDA Approves Taiho's LYTGOBI (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma - Vimarsana News

Taiho Oncology, Inc.: FDA Approves Taiho's LYTGOBI (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

LYTGOBI (pronounced "light-GOH-bee") delivered an objective response rate of 42% and median duration of response of 9.7 months in the primary analysis of the pivotal clinical trial. LYTGOBI

FDA Approves Taiho's LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma - Vimarsana News

FDA Approves Taiho's LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

LYTGOBI (pronounced 'light-GOH-bee') delivered an objective response rate of 42% and median duration of response of 9.7 months in the primary anal...

Enjoy Live Music & Beautiful Art At Kentuck's May Art Night - Vimarsana News

Enjoy Live Music & Beautiful Art At Kentuck's May Art Night

Enjoy Live Music & Beautiful Art At Kentuck's May Art Night  Are you a lover of the arts? What if you're just looking to get out of the house with the family? Kentuck's May Art Night is the place to be! Get our free mobile app I was literally just talking with my wife about art pieces. While watching Netflix, we saw a bunch of art hanging on a wall and went into a 10-minute conversation about art. We enjoy discussing and looking at great together. Once a month, we can do exactly that with our whole family at Kentuck's Art Night.

Source: wtug.com